Home » Ariad Pharma Sets Sights on Two Marketed Cancer Drugs
Ariad Pharma Sets Sights on Two Marketed Cancer Drugs
Like Millennium has done with its game-changing cancer treatment bortezomib (Velcade), Ariad now has a big opportunity with the lead cancer drug in its pipeline, ridaforolimus.
Xconomy
Xconomy
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May